Rep. La Shawn K. Ford

Filed: 3/16/2017

 

 


 

 


 
10000HB0236ham001LRB100 04181 KTG 23676 a

1
AMENDMENT TO HOUSE BILL 236

2    AMENDMENT NO. ______. Amend House Bill 236 by replacing
3everything after the enacting clause with the following:
 
4    "Section 5. The Illinois Public Aid Code is amended by
5changing Sections 5-2b and 5-4.1 as follows:
 
6    (305 ILCS 5/5-2b)
7    Sec. 5-2b. Medically fragile and technology dependent
8children eligibility and program. Notwithstanding any other
9provision of law, on and after September 1, 2012, subject to
10federal approval, medical assistance under this Article shall
11be available to children who qualify as persons with a
12disability, as defined under the federal Supplemental Security
13Income program and who are medically fragile and technology
14dependent. The program shall allow eligible children to receive
15the medical assistance provided under this Article in the
16community and must maximize, to the fullest extent permissible

 

 

10000HB0236ham001- 2 -LRB100 04181 KTG 23676 a

1under federal law, federal reimbursement and family
2cost-sharing, including co-pays for brand name prescription
3drugs, premiums, or any other family contributions, except that
4the Department shall be permitted to incentivize the
5utilization of selected services through the use of
6cost-sharing adjustments. The Department shall establish the
7policies, procedures, standards, services, and criteria for
8this program by rule.
9(Source: P.A. 97-689, eff. 6-14-12; 98-104, eff. 7-22-13.)
 
10    (305 ILCS 5/5-4.1)  (from Ch. 23, par. 5-4.1)
11    Sec. 5-4.1. Co-payments; limitations. The Department may
12not require recipients of benefits under any Article of this
13Code to pay a fee as a co-payment for any service or generic
14drug or prescribed over-the-counter drug covered under the fee
15for service or managed care medical assistance programs. The
16Department may by rule provide that recipients under any
17Article of this Code shall pay a fee as a co-payment for brand
18name prescription drugs. services. Co-payments shall be
19maximized to the extent permitted by federal law, except that
20the Department shall impose a co-pay of $2 on generic drugs.
21Provided, however, that any such rule must provide that no
22co-payment requirement can exist for renal dialysis, radiation
23therapy, cancer chemotherapy, or insulin, and other products
24necessary on a recurring basis, the absence of which would be
25life threatening, or where co-payment expenditures for

 

 

10000HB0236ham001- 3 -LRB100 04181 KTG 23676 a

1required services and/or medications for chronic diseases that
2the Illinois Department shall by rule designate shall cause an
3extensive financial burden on the recipient, and provided no
4co-payment shall exist for emergency room encounters which are
5for medical emergencies. The Department shall seek approval of
6a State plan amendment that allows pharmacies to refuse to
7dispense brand name prescription drugs in circumstances where
8the recipient does not pay the required co-payment for a brand
9name prescription drug. Co-payments may not exceed $10 for
10emergency room use for a non-emergency situation as defined by
11the Department by rule and subject to federal approval.
12(Source: P.A. 96-1501, eff. 1-25-11; 97-74, eff. 6-30-11;
1397-689, eff. 6-14-12.)".